CONCENTRIX ($CNXC) posted quarterly earnings results for Q4 2025 on Tuesday, January 13th. The company reported earnings of $2.95 per share, missing estimates of $2.97 by $0.02. The company also reported revenue of $2,552,930,000, missing estimates of $2,590,068,660 by $-37,138,660.
You can see Quiver Quantitative's $CNXC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CONCENTRIX Insider Trading Activity
CONCENTRIX insiders have traded $CNXC stock on the open market 8 times in the past 6 months. Of those trades, 4 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CNXC stock by insiders over the last 6 months:
- CHRISTOPHER A CALDWELL (President and CEO) has made 4 purchases buying 5,000 shares for an estimated $216,840 and 0 sales.
- CORMAC J TWOMEY (EVP, Global Ops & Delivery) has made 0 purchases and 4 sales selling 2,000 shares for an estimated $93,095.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CONCENTRIX Hedge Fund Activity
We have seen 170 institutional investors add shares of CONCENTRIX stock to their portfolio, and 166 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 1,866,053 shares (+194.0%) to their portfolio in Q3 2025, for an estimated $86,118,345
- DEPRINCE RACE & ZOLLO INC added 688,360 shares (+inf%) to their portfolio in Q3 2025, for an estimated $31,767,814
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 535,843 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $24,729,154
- PRUDENTIAL FINANCIAL INC added 322,257 shares (+inf%) to their portfolio in Q3 2025, for an estimated $14,872,160
- DIMENSIONAL FUND ADVISORS LP added 301,550 shares (+18.4%) to their portfolio in Q3 2025, for an estimated $13,916,532
- MAN GROUP PLC removed 286,646 shares (-89.3%) from their portfolio in Q3 2025, for an estimated $13,228,712
- ATOMVEST LTD added 284,187 shares (+inf%) to their portfolio in Q3 2025, for an estimated $13,115,230
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CONCENTRIX Analyst Ratings
Wall Street analysts have issued reports on $CNXC in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 11/20/2025
- Baird issued a "Outperform" rating on 09/29/2025
- Canaccord Genuity issued a "Buy" rating on 09/26/2025
To track analyst ratings and price targets for CONCENTRIX, check out Quiver Quantitative's $CNXC forecast page.
CONCENTRIX Price Targets
Multiple analysts have issued price targets for $CNXC recently. We have seen 4 analysts offer price targets for $CNXC in the last 6 months, with a median target of $71.0.
Here are some recent targets:
- Vincent Colicchio from Barrington Research set a target price of $62.0 on 01/12/2026
- David Koning from Baird set a target price of $62.0 on 09/29/2025
- Luke Morison from Canaccord Genuity set a target price of $80.0 on 09/26/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
